Ventringo 8 mg tablete
| Name | Ventringo 8 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-465714712 |
| Active Substance | betahistindiklorid |
| Composition | jedna tableta sadrži 8 mg betahistindiklorida |
| Pharmaceutical Form | Tableta |
| Manufacturer | Emona Biopharma razvoj proizvodnja in prodaja d.o.o., Ljubljana, Slovenija
Terapia S.A., Cluj-Napoca, Rumunjska |
| Marketing Authorisation Holder | PharmaS d.o.o., Radnička cesta 47, Zagreb, Hrvatska |
| Marketing Authorisation Date | 03.08.2026 |
| MA Period of Validity | 09.04.2030 |
| Classification Number | UP/I-530-09/23-01/24 |
| Registration Number | 381-12-01/286-26-19 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | N07CA01 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
